Open Access<p>Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies</p>
Author(s) -
Ashfaq Ahmad,
Farhat Ullah,
Abdul Sadiq,
Muhammad Ayaz,
Haroon Rahim,
Umer Rashid,
Sajjad Ahmad,
Muhammad Saeed Jan,
Riaz Ullah,
Abdelaaty A. Shahat,
Hafiz Majid Mahmood
Publication year - 2019
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s226080
Subject(s) - mcf 7 , chemistry , antioxidant , enzyme , cancer research , cell culture , biochemistry , cancer , pharmacology , microbiology and biotechnology , cancer cell , medicine , biology , genetics , human breast
The current work was designed to synthesize a bioactive derivative of succinimide and evaluate it for anti-Alzheimer, anticancer and anti-diabetic potentials.